Showing results (1-10 of 32) with videos related to
Sort By:
Pageof 4
Clinical Microbiology Reviews|July 3, 2020
The Echo of Pulmonary Tuberculosis: Mechanisms of Clinical Symptoms and Other Disease-Induced Systemic ComplicationsLaneke Luies, Ilse du PreezOmics : a Journal of Integrative Biology|September 13, 2012
Altered fatty acid metabolism due to rifampicin-resistance conferring mutations in the rpoB Gene of Mycobacterium tuberculosis: mapping the potential of pharmaco-metabolomics for global health and personalized medicineIlse du Preez, Du Toit LootsDrug Metabolism Reviews|December 19, 2018
Novel insights into the pharmacometabonomics of first-line tuberculosis drugs relating to metabolism, mechanism of action and drug-resistanceIlse Du Preez, Du Toit LootsMethods in Molecular Biology (Clifton, N.J.)|November 14, 2018
Total Metabolome Extraction from Mycobacterial Cells for GC-MS Metabolomics AnalysisDerylize Beukes, Ilse du Preez, Du Toit LootsTuberculosis (Edinburgh, Scotland)|April 6, 2019
The application of metabolomics toward pulmonary tuberculosis researchIlse du Preez, Laneke Luies, Du Toit LootsBiomarkers in Medicine|January 19, 2017
Metabolomics biomarkers for tuberculosis diagnostics: current status and future objectivesIlse du Preez, Laneke Luies, Du Toit LootsBiomarkers in Medicine|October 18, 2017
The role of metabolomics in tuberculosis treatment researchLaneke Luies, Ilse du Preez, Du Toit LootsMethods in Molecular Biology (Clifton, N.J.)|November 14, 2018
Fatty Acid Metabolome Extraction from Mycobacterial Cells for GC-MS Metabolomics AnalysisIlse du Preez, Derylize Beukes, Du Toit LootsAdvances in Protein Chemistry and Structural Biology|February 2, 2016
Metabolomics and Personalized MedicineNadia Koen, Ilse Du Preez, Du Toit LootsToxicology Letters|January 26, 2020
Metabolomics describes previously unknown toxicity mechanisms of isoniazid and rifampicinMonique Combrink, Du Toit Loots, Ilse du PreezPageof 4